Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Polycythemia and renal infarction in a bodybuilder.
Ammatuna E, Nijziel MR. Ammatuna E, et al. QJM. 2014 Aug;107(8):661-2. doi: 10.1093/qjmed/hcu042. Epub 2014 Feb 19. QJM. 2014. PMID: 24557731 No abstract available.
Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia: should this be the first choice to establish the diagnosis of APL?
Ammatuna E. Ammatuna E. Int J Hematol. 2016 Jul;104(1):144-5. doi: 10.1007/s12185-016-1994-2. Epub 2016 Apr 2. Int J Hematol. 2016. PMID: 27038630 No abstract available.
Bluish-grey pigmentation of the facial skin and lower legs.
Ammatuna E, van Henten A, Erdtsieck R. Ammatuna E, et al. Neth J Med. 2013 Apr;71(3):138, 142. Neth J Med. 2013. PMID: 23712811 No abstract available.
The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment.
Lo-Coco F, Ammatuna E. Lo-Coco F, et al. Among authors: ammatuna e. Hematology Am Soc Hematol Educ Program. 2006:156-61, 514. doi: 10.1182/asheducation-2006.1.156. Hematology Am Soc Hematol Educ Program. 2006. PMID: 17124055 Review.
Such genotypic and phenotypic features are targeted by agents currently in use in front-line therapy or at relapse (i.e., retinoids, arsenic trioxide, anthracyclines and anti-CD33 monoclonal antibodies), and by novel agents that may find a place in future treatments such a …
Such genotypic and phenotypic features are targeted by agents currently in use in front-line therapy or at relapse (i.e., retinoids, …
Treatment of acute promyelocytic leukemia with gemtuzumab ozogamicin.
Lo Coco F, Ammatuna E, Noguera N. Lo Coco F, et al. Among authors: ammatuna e. Clin Adv Hematol Oncol. 2006 Jan;4(1):57-62, 76-7. Clin Adv Hematol Oncol. 2006. PMID: 16562371 Review.
Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F, Ammatuna E, Montesinos P, Sanz MA. Lo-Coco F, et al. Among authors: ammatuna e. Semin Oncol. 2008 Aug;35(4):401-9. doi: 10.1053/j.seminoncol.2008.04.010. Semin Oncol. 2008. PMID: 18692690
Two cases of q-Fever in hairy cell leukemia.
Ammatuna E, Iannitto E, Tick LW, Arents NL, Kuijper PH, Nijziel MR. Ammatuna E, et al. Case Rep Hematol. 2014;2014:863932. doi: 10.1155/2014/863932. Epub 2014 Aug 12. Case Rep Hematol. 2014. PMID: 25180111 Free PMC article.
Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.
Ammatuna E, Eefting M, van Lom K, Kavelaars FG, Valk PJ, Touw IP. Ammatuna E, et al. Ann Hematol. 2015 May;94(5):879-80. doi: 10.1007/s00277-014-2272-0. Epub 2014 Dec 11. Ann Hematol. 2015. PMID: 25491280 No abstract available.
Current treatment of acute promyelocytic leukemia.
Lo Coco F, Ammatuna E, Sanz MA. Lo Coco F, et al. Among authors: ammatuna e. Haematologica. 2007 Mar;92(3):289-91. doi: 10.3324/haematol.11226. Haematologica. 2007. PMID: 17339175 No abstract available.
59 results
Jump to page
Feedback